Yamini Bhusan Tripathi

6PUBLICATIONS
11CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Proteins and peptidesComputational complexity and computabilityBiologically active moleculesImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 03, 2022
Impact of Nano Preparation of Phytoconstituents in Medulloblastoma.

Priyanka Mishra, Y B Tripathi

|Nov 25, 2021
Phytonutrient Inhibitors of SARS-CoV-2/NSP5-Encoded Main Protease (Mpro) Autocleavage Enzyme Critical for COVID-19 Pathogenesis.

Sreus A G Naidu, Yamini B Tripathi, Priya Shree

|Aug 23, 2021
In silico screening of Pueraria tuberosa (PTY-2) for targeting COVID-19 by countering dual targets Mpro and TMPRSS2.

Priya Shree, Priyanka Mishra, Prateek Kumar

|Aug 28, 2020
Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants - Withania somnifera (Ashwagandha), Tinospora cordifolia (Giloy) and Ocimum sanctum (Tulsi) - a molecular docking study.

Priya Shree, Priyanka Mishra, Chandrabose Selvaraj

|Aug 06, 2019
GLP 1 Regulated Intestinal Cell's Insulin Expression and Selfadaptation before the Onset of Type 2 Diabetes.

Shivani Srivastava, Harsh Pandey, Surya Kumar Singh

|May 18, 2018
Pueraria tuberosa extract inhibits iNOS and IL-6 through suppression of PKC-α and NF-kB pathway in diabetes-induced nephropathy.

Rashmi Shukla, Somanshu Banerjee, Yamini B Tripathi

Pageof 1

Frequent Collaborators

3 joint publications

Priyanka Mishra

3 joint publications

Priya Shree

2 joint publications

Radha Chaube

2 joint publications

Neha Garg